AMRX
Amneal Pharmaceuticals
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: AMRX
- PE Ratio
As at Sep 22, 2026, the AMRX stock has a price-to-earnings ratio of 39.0. This is based on the current EPS of $0.5 and the stock price of $19.5 per share. A decrease of 75% has been recorded in the P/E ratio compared to the average of 155.4 of the last 4 quarters.
AMRX PE ratio history
The mean historical PE ratio of Amneal Pharmaceuticals over the last six years is 160.03. The current 39.0 PE ratio is 76% below the historical average. In the past six years, AMRX's PE ratio was at its highest in the Jun 2025 quarter at 809, with a price of $8.09 and an EPS of $0.01. The Dec 2020 quarter recorded the bottom point at 7.37, with a price of $4.57 and an EPS of $0.62.
Amneal Pharmaceuticals PE ratio by year
Maximum annual increase: 828.49% in 2021
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 54.78 | N/A | $12.6 | $0.23 |
| 2024 | N/A | N/A | $7.92 | -$0.38 |
| 2023 | N/A | N/A | $6.07 | -$0.48 |
| 2022 | N/A | N/A | $1.99 | -$0.86 |
| 2021 | 68.43 | 828.49% | $4.79 | $0.07 |
| 2020 | 7.37 | N/A | $4.57 | $0.62 |
| 2019 | N/A | N/A | $4.82 | -$2.74 |
| 2018 | N/A | N/A | $13.53 | -$0.16 |
| 2017 | N/A | N/A | N/A | N/A |
| 2016 | N/A | N/A | N/A | N/A |
| 2015 | N/A | N/A | N/A | N/A |
| 2014 | N/A | N/A | N/A | N/A |
Amneal Pharmaceuticals PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Jun 2026 | 34.62 | 8.63% | $17.31 | $0.5 |
| Mar 2026 | 31.87 | -41.82% | $12.43 | $0.39 |
| Dec 2025 | 54.78 | -89.05% | $12.6 | $0.23 |
| Sep 2025 | 500.5 | -38.13% | $10.01 | $0.02 |
| Jun 2025 | 809 | N/A | $8.09 | $0.01 |
| Mar 2025 | N/A | N/A | $8.38 | -$0.04 |
| Dec 2024 | N/A | N/A | $7.92 | -$0.38 |
| Sep 2024 | N/A | N/A | $8.32 | -$0.86 |
| Jun 2024 | N/A | N/A | $6.35 | -$0.8 |
| Mar 2024 | N/A | N/A | $6.06 | -$0.74 |
| Dec 2023 | N/A | N/A | $6.07 | -$0.48 |
| Sep 2023 | 70.33 | N/A | $4.22 | $0.06 |
| Jun 2023 | N/A | N/A | $3.1 | -$0.02 |
| Mar 2023 | N/A | N/A | $1.39 | -$0.9 |
| Dec 2022 | N/A | N/A | $1.99 | -$0.86 |
AMRX Price vs fair value
AMRX average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
AMRX's current P/E ratio is lower than the 3 and 5-year averages.
PE comparison
With a P/E of 39, AMRX stands above the Healthcare sector and the industry average. Compared to its Healthcare sector average of 23.65, Amneal Pharmaceuticals's P/E is 65% higher.
Frequently asked questions
What is Amneal Pharmaceuticals's PE ratio?
The price to earnings ratio for AMRX stock as of Sep 22, 2026, stands at 39.
What is the 3-year average PE ratio for Amneal Pharmaceuticals (AMRX)?
As an average over the last 3 years, AMRX stock has a PE ratio of 250.18.
What is the 5-year average PE ratio for Amneal Pharmaceuticals (AMRX)?
As an average over the last 5 years, AMRX stock has a PE ratio of 203.49.
What is the highest PE ratio for AMRX?
The highest quarterly PE ratio in the last six years has been 809 and it was in the Jun 2025 quarter.
How does the current PE ratio for AMRX compare to its historical average?
AMRX's current price to earnings ratio is 76% below its 6-year historical average.
How is AMRX's PE ratio calculated (Amneal Pharmaceuticals PE ratio formula)?
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Sep 22, 2026), Amneal Pharmaceuticals's stock price is $19.5. The earnings per share for the trailing twelve months (TTM) ending Jun 2026 is $0.5. Therefore, Amneal Pharmaceuticals's P/E ratio for today is 39. PE RATIO(39) = STOCK PRICE($19.5) / TTM EPS($0.5)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.